50 research outputs found
Formation of metallic magnetic clusters in a Kondo-lattice metal: Evidence from an optical study
Magnetic materials are usually divided into two classes: those with localised
magnetic moments, and those with itinerant charge carriers. We present a
comprehensive experimental (spectroscopic ellipsomerty) and theoretical study
to demonstrate that these two types of magnetism do not only coexist but
complement each other in the Kondo-lattice metal, Tb2PdSi3. In this material
the itinerant charge carriers interact with large localised magnetic moments of
Tb(4f) states, forming complex magnetic lattices at low temperatures, which we
associate with self-organisation of magnetic clusters. The formation of
magnetic clusters results in low-energy optical spectral weight shifts, which
correspond to opening of the pseudogap in the conduction band of the itinerant
charge carriers and development of the low- and high-spin intersite electronic
transitions. This phenomenon, driven by self-trapping of electrons by magnetic
fluctuations, could be common in correlated metals, including besides
Kondo-lattice metals, Fe-based and cuprate superconductors.Comment: 30 pages, 6 Figure
Evaluation of the antibacterial activity of the preparation benzydamine hydrochloride
Introduction. With an increase in the level of acquired antibiotic resistance of pathogens, treatment becomes more complicated and slows down, especially in infections associated with biofilms. There is a growing need for the development and use of new antibacterial drugs with specific antimicrobial activity.Aim. To study the antimicrobial action and the dynamics of the formation of resistance to benzydamine hydrochloride from a various infection agents.Β Materials and methods. To obtain biofilms, microorganisms were cultivated in flat-bottomed culture plates. Planktonic cells were obtained by suspending and reseeding single colonies of the daily culture into flat-bottomed culture plates. To determine the antimicrobial activity of the studied preparations, two-fold dilutions were prepared and added to the wells of the plate with a bacterial culture. The dynamics of the formation of resistance to benzydamine hydrochloride was studied by passaging the cultures in a liquid nutrient medium with increasing concentrations of the antiseptic by a twofold step. After 2β3 days of incubation from a test tube with the maximum concentration of the drug, in which bacterial growth was observed, the bacteria were transferred to new ones with higher concentrations of the drug.Results. It was shown that benzydamine hydrochloride showed a high level of activity against bacteria M. catarrhalis and yeast-like fungi C. albicans. A slightly lower activity of the drug was noted for bacteria of the species S. aureus and E. coli, however, within the limits of the therapeutic concentration of the drug in finished dosage forms. Benzydamine hydrochloride had a significantly higher level of antibacterial activity against pre-formed biofilms compared to drugs such as chlorhexidine and hexetidine. An analysis of the dynamics of the formation of resistance to the drug benzydamine hydrochloride in microorganisms of various species showed that the possibility of developing resistance to benzydamine hydrochloride is extremely small. The process of adaptation was observed only in E. coli. The studied strains of the species S. aureus, C. albicans, and M. catarrhalis did not acquire resistance to the test drug.Conclusion. Benzydamine hydrochloride can be effectively used against a wide range of pathogens of ENT infections, as it has been shown to have a significantly higher level of antibacterial activity against pre-formed biofilms, various types of bacteria and yeast-like fungi and an extremely low level of resistance compared to other antiseptic drugs
ΠΠ°Π½Π΄ΠΈΠ΄Π΅ΠΌΠΈΡ Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π±ΠΎΠ»ΡΠ½ΡΡ : ΡΠ΅Π½ΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Ρ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ³ΡΠΈΠ±ΠΊΠΎΠ²ΡΠΌ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΠΌ ΡΡΠ΅Π΄ΡΡΠ²Π°ΠΌ, Π³Π΅Π½Ρ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ Candida spp.
Relevance. The global trend of rapid increase in resistance to antifungal drugs due to multiple factors, dictates the need for continuous monitoring of taxonomic structure and susceptibility of nosocomial pathogens, causing invasive fungal infections, for permanent correction of the optimal prevention and treatment strategies.Purpose: to determine antifungal susceptibility of the main yeast pathogens in candidemia in cancer patients, as well as to determine resistance genes and pathogenic factor genes.Material and Methods. Eighty-two strains of Candida spp. isolated from blood of cancer patients from 2015 to 2021 were analyzed. Minimum inhibitory concentrations of fuconazole, voriconazole, posaconazole, anidulafungin and micafungin were determined by a gradient method (E-test, BioMerieux, France). The EUCAST and CLSI criteria were used for MIC value assessment. The genes, associated with pathogenicity factors, and resistance to antifungal drugs were identifed.Results. Our study results based on EUCAST 2020, v.10.0 criteria showed that triazoles, especially fuconazole, were the least effective drugs in empirical therapy for invasive candidiasis (including candidemia). Resistance of Candida spp. fuconazole was superior to that of voriconazole (47.2 % vs 23.2 %, respectively, p<0.01) and posaconazole (47.2 % vs 30.4 %, respectively, p><0.05). The highest in vitro activity was observed in echinocandins, and anidulafungin was 2 times more active than micafungin (4.1 % of resistant strains vs 11.4 %, respectively), with no statistically signifcant difference (p>0.05). The ERG11 and FKS1 genes associated with resistance to antifungal drugs were detected in 28.6 % of Candida spp. strains. The ERG11 gene was detected in 8.6 % of cases, exclusively in Candida albicans strains. The FKS1 gene was identifed in 20.0 % of strains (85.7 % of them were C. parapsilosis, 7.1 % each were C. tropicalis and C. glabrata). Pathogenic factor genes were identifed in 78.6 % of C. albicans and in 79.1 % of C. parapsilosis strains.Conclusion. Molecular genetic methods for the detection of Candida spp strains carrying resistance genes to antifungal drugs, and the determination of pathogenicity factors are promising trends in searching for biomarkers. They facilitate interpretation of results of microbiological study to assess the ability of Candida spp. strains to develop invasive mycoses.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. ΠΠΈΡΠΎΠ²Π°Ρ ΡΠ΅Π½Π΄Π΅Π½ΡΠΈΡ ΡΡΡΠ΅ΠΌΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ ΡΡΠΎΠ²Π½Ρ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ³ΡΠΈΠ±ΠΊΠΎΠ²ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ, ΠΊΠΎΡΠΎΡΠ°Ρ ΡΠ²ΡΠ·Π°Π½Π° ΡΠΎ ΠΌΠ½ΠΎΠ³ΠΈΠΌΠΈ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌΠΈ, Π΄ΠΈΠΊΡΡΠ΅Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΏΠΎΡΡΠΎΡΠ½Π½ΠΎΠ³ΠΎ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° ΡΠ°ΠΊΡΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ Π½ΠΎΠ·ΠΎΠΊΠΎΠΌΠΈΠ°Π»ΡΠ½ΡΡ
Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΡ
Π³ΡΠΈΠ±ΠΊΠΎΠ²ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ ΠΈ ΠΈΡ
ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΊ Π°Π½ΡΠΈΡΡΠ½Π³Π°Π»ΡΠ½ΡΠΌ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΠΌ ΡΡΠ΅Π΄ΡΡΠ²Π°ΠΌ Ρ ΡΠ΅Π»ΡΡ ΠΏΠΎΡΡΠΎΡΠ½Π½ΠΎΠΉ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΠΎΠΏΡΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ°ΠΊΡΠΈΠΊΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΡ
Π³ΡΠΈΠ±ΠΊΠΎΠ²ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΊ Π°Π½ΡΠΈΡΡΠ½Π³Π°Π»ΡΠ½ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»Π΅ΠΉ ΠΏΡΠΈ ΠΊΠ°Π½Π΄ΠΈΠ΄Π΅ΠΌΠΈΠΈ Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ Π³Π΅Π½ΠΎΠ² ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½ΠΎ 82 ΡΡΠ°ΠΌΠΌΠ° Candida spp., Π²ΡΠ΄Π΅Π»Π΅Π½Π½ΡΡ
ΠΈΠ· ΠΊΡΠΎΠ²ΠΈ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 2015β21 Π³Π³. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΡΡ
ΠΈΠ½Π³ΠΈΠ±ΠΈΡΡΡΡΠΈΡ
ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΉ ΡΠ»ΡΠΊΠΎΠ½Π°Π·ΠΎΠ»Π°, Π²ΠΎΡΠΈΠΊΠΎΠ½Π°Π·ΠΎΠ»Π°, ΠΏΠΎΠ·Π°ΠΊΠΎΠ½Π°Π·ΠΎΠ»Π°, Π°Π½ΠΈΠ΄ΡΠ»Π°ΡΡΠ½Π³ΠΈΠ½Π° ΠΈ ΠΌΠΈΠΊΠ°ΡΡΠ½Π³ΠΈΠ½Π° Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ Π³ΡΠ°Π΄ΠΈΠ΅Π½ΡΠ½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ (Π-ΡΠ΅ΡΡ, BioMerieux, France). ΠΠ»Ρ ΠΎΡΠ΅Π½ΠΊΠΈ Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ ΠΠΠ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ EUCAST ΠΈ CLSI. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ Π³Π΅Π½Ρ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ Ρ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌΠΈ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ ΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ³ΡΠΈΠ±ΠΊΠΎΠ²ΡΠΌ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΠΌ ΡΡΠ΅Π΄ΡΡΠ²Π°ΠΌ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ Π½Π°ΡΠ΅Π³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ (ΠΊΡΠΈΡΠ΅ΡΠΈΠΈ EUCAST) Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΡΠΌΠΏΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΊΠ°Π½Π΄ΠΈΠ΄ΠΎΠ·Π° (Π² Ρ. Ρ. ΠΊΠ°Π½Π΄ΠΈΠ΄Π΅ΠΌΠΈΠΈ) Π½Π°ΠΈΠΌΠ΅Π½Π΅Π΅ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌΠΈ ΡΠ²Π»ΡΡΡΡΡ ΡΡΠΈΠ°Π·ΠΎΠ»Ρ, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ ΡΠ»ΡΠΊΠΎΠ½Π°Π·ΠΎΠ», ΠΊ ΠΊΠΎΡΠΎΡΠΎΠΌΡ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ ΡΠ°ΡΠ΅ ΡΡΠ°ΠΌΠΌΡ Candida spp. ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½Ρ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ Π²ΠΎΡΠΈΠΊΠΎΠ½Π°Π·ΠΎΠ»ΠΎΠΌ (47,2 % ΠΏΡΠΎΡΠΈΠ² 23,2 %, p<0,01) ΠΈ ΠΏΠΎΠ·Π°ΠΊΠΎΠ½Π°Π·ΠΎΠ»ΠΎΠΌ (47,2 % ΠΏΡΠΎΡΠΈΠ² 30,4 %, p><0,05). ΠΠ°ΠΈΠ±ΠΎΠ»ΡΡΠ°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ in vitro ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ Ρ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΡ
ΠΈΠ½ΠΎΠΊΠ°Π½Π΄ΠΈΠ½ΠΎΠ², ΠΏΡΠΈΡΠ΅ΠΌ Π°Π½ΠΈΠ΄ΡΠ»Π°ΡΡΠ½Π³ΠΈΠ½ Π² 2 ΡΠ°Π·Π° Π°ΠΊΡΠΈΠ²Π½Π΅Π΅ ΠΌΠΈΠΊΠ°ΡΡΠ½Π³ΠΈΠ½Π° (4,1 % ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΡΡΠ°ΠΌΠΌΠΎΠ² ΠΏΡΠΎΡΠΈΠ² 11,4 %), Π½ΠΎ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ ΡΠ°Π·Π½ΠΈΡΡ ΠΏΡΠΈ ΡΡΠΎΠΌ Π½Π΅ Π²ΡΡΠ²Π»Π΅Π½ΠΎ. ΠΠ΅Π½Ρ ERG11 ΠΈ FKS1, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ Ρ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΡΡ ΠΊ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ³ΡΠΈΠ±ΠΊΠΎΠ²ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ, Π±ΡΠ»ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ Ρ 28,6 % ΡΡΠ°ΠΌΠΌΠΎΠ² Candida spp.. ΠΠ΅Π½ ERG11 Π΄Π΅ΡΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ Π² 8,6 % ΡΠ»ΡΡΠ°Π΅Π², ΠΏΡΠΈΡΠ΅ΠΌ ΡΠΎΠ»ΡΠΊΠΎ Ρ ΡΡΠ°ΠΌΠΌΠΎΠ² Candida albicans. ΠΠ΅Π½ FKS1 ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ Ρ 20,0 % ΡΡΠ°ΠΌΠΌΠΎΠ² (85,7 % β C. parapsilosis, ΠΏΠΎ 7,1 % β C. tropicalis ΠΈ C. glabrata). ΠΠ΅Π½Ρ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ Ρ 78,6 % ΡΡΠ°ΠΌΠΌΠΎΠ² C. albicans ΠΈ Ρ 79,1 % ΠΈΠ·ΠΎΠ»ΡΡΠΎΠ² C. parapsilosis. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΡΡΠ°ΠΌΠΌΠΎΠ² Candida spp., Π½Π΅ΡΡΡΠΈΡ
Π³Π΅Π½Ρ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊ Π°Π½ΡΠΈΡΡΠ½Π³Π°Π»ΡΠ½ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ β><Β 0,01) ΠΈ ΠΏΠΎΠ·Π°ΠΊΠΎΠ½Π°Π·ΠΎΠ»ΠΎΠΌ (47,2 % ΠΏΡΠΎΡΠΈΠ² 30,4 %, p<0,05). ΠΠ°ΠΈΠ±ΠΎΠ»ΡΡΠ°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ in vitro ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ Ρ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΡ
ΠΈΠ½ΠΎΠΊΠ°Π½Π΄ΠΈΠ½ΠΎΠ², ΠΏΡΠΈΡΠ΅ΠΌ Π°Π½ΠΈΠ΄ΡΠ»Π°ΡΡΠ½Π³ΠΈΠ½ Π² 2 ΡΠ°Π·Π° Π°ΠΊΡΠΈΠ²Π½Π΅Π΅ ΠΌΠΈΠΊΠ°ΡΡΠ½Π³ΠΈΠ½Π° (4,1 % ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΡΡΠ°ΠΌΠΌΠΎΠ² ΠΏΡΠΎΡΠΈΠ² 11,4 %), Π½ΠΎ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ ΡΠ°Π·Π½ΠΈΡΡ ΠΏΡΠΈ ΡΡΠΎΠΌ Π½Π΅ Π²ΡΡΠ²Π»Π΅Π½ΠΎ. ΠΠ΅Π½Ρ ERG11 ΠΈ FKS1, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ Ρ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΡΡ ΠΊ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ³ΡΠΈΠ±ΠΊΠΎΠ²ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ, Π±ΡΠ»ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ Ρ 28,6 % ΡΡΠ°ΠΌΠΌΠΎΠ² Candida spp.. ΠΠ΅Π½ ERG11 Π΄Π΅ΡΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ Π² 8,6 % ΡΠ»ΡΡΠ°Π΅Π², ΠΏΡΠΈΡΠ΅ΠΌ ΡΠΎΠ»ΡΠΊΠΎ Ρ ΡΡΠ°ΠΌΠΌΠΎΠ² Candida albicans. ΠΠ΅Π½ FKS1 ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ Ρ 20,0 % ΡΡΠ°ΠΌΠΌΠΎΠ² (85,7 % β C. parapsilosis, ΠΏΠΎ 7,1 % β C. tropicalis ΠΈ C. glabrata). ΠΠ΅Π½Ρ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ Ρ 78,6 % ΡΡΠ°ΠΌΠΌΠΎΠ² C. albicans ΠΈ Ρ 79,1 % ΠΈΠ·ΠΎΠ»ΡΡΠΎΠ² C. parapsilosis. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΡΡΠ°ΠΌΠΌΠΎΠ² Candida spp., Π½Π΅ΡΡΡΠΈΡ
Π³Π΅Π½Ρ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊ Π°Π½ΡΠΈΡΡΠ½Π³Π°Π»ΡΠ½ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ β>< 0,05). ΠΠ°ΠΈΠ±ΠΎΠ»ΡΡΠ°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ in vitro ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ Ρ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΡΡ
ΠΈΠ½ΠΎΠΊΠ°Π½Π΄ΠΈΠ½ΠΎΠ², ΠΏΡΠΈΡΠ΅ΠΌ Π°Π½ΠΈΠ΄ΡΠ»Π°ΡΡΠ½Π³ΠΈΠ½ Π² 2 ΡΠ°Π·Π° Π°ΠΊΡΠΈΠ²Π½Π΅Π΅ ΠΌΠΈΠΊΠ°ΡΡΠ½Π³ΠΈΠ½Π° (4,1 % ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ
ΡΡΠ°ΠΌΠΌΠΎΠ² ΠΏΡΠΎΡΠΈΠ² 11,4 %), Π½ΠΎ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠΉ ΡΠ°Π·Π½ΠΈΡΡ ΠΏΡΠΈ ΡΡΠΎΠΌ Π½Π΅ Π²ΡΡΠ²Π»Π΅Π½ΠΎ. ΠΠ΅Π½Ρ ERG11 ΠΈ FKS1, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ Ρ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΡΡ ΠΊ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ³ΡΠΈΠ±ΠΊΠΎΠ²ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ, Π±ΡΠ»ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ Ρ 28,6 % ΡΡΠ°ΠΌΠΌΠΎΠ² Candida spp.. ΠΠ΅Π½ ERG11 Π΄Π΅ΡΠ΅ΠΊΡΠΈΡΠΎΠ²Π°Π½ Π² 8,6 % ΡΠ»ΡΡΠ°Π΅Π², ΠΏΡΠΈΡΠ΅ΠΌ ΡΠΎΠ»ΡΠΊΠΎ Ρ ΡΡΠ°ΠΌΠΌΠΎΠ² Candida albicans. ΠΠ΅Π½ FKS1 ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ Ρ 20,0 % ΡΡΠ°ΠΌΠΌΠΎΠ² (85,7 % β C. parapsilosis, ΠΏΠΎ 7,1 % β C. tropicalis ΠΈ C. glabrata). ΠΠ΅Π½Ρ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ Ρ 78,6 % ΡΡΠ°ΠΌΠΌΠΎΠ² C. albicans ΠΈ Ρ 79,1 % ΠΈΠ·ΠΎΠ»ΡΡΠΎΠ² C. parapsilosis.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄Ρ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ ΡΡΠ°ΠΌΠΌΠΎΠ² Candida spp., Π½Π΅ΡΡΡΠΈΡ
Π³Π΅Π½Ρ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊ Π°Π½ΡΠΈΡΡΠ½Π³Π°Π»ΡΠ½ΡΠΌ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌ, ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΠΎΡΡΠΈ β ΡΡΠΎ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΡ Π΄Π»Ρ ΠΏΠΎΠΈΡΠΊΠ° Π±ΠΈΠΎΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ², ΠΎΠ±Π»Π΅Π³ΡΠ°ΡΡΠΈΡ
ΡΠ»ΠΎΠΆΠ½ΡΡ Π·Π°Π΄Π°ΡΡ ΡΡΠ°ΠΊΡΠΎΠ²ΠΊΠΈ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΎΠ² ΠΌΠΈΠΊΡΠΎΠ±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎ ΠΎΡΠ΅Π½ΠΊΠ΅ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΠΈ ΡΡΠ°ΠΌΠΌΠΎΠ² Candida spp. ΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΡ
ΠΌΠΈΠΊΠΎΠ·ΠΎΠ²
The spread of bla OXA-48 and bla OXA-244 carbapenemase genes among Klebsiella pneumoniae, Proteus mirabilis and Enterobacter spp. isolated in Moscow, Russia
Chilling acclimation provides immunity to stress by altering regulatory networks and inducing genes with protective functions in Cassava
A transcriptomic analysis of bermudagrass (Cynodon dactylon) provides novel insights into the basis of low temperature tolerance
Antibacterial Activity of Benzydamine Hydrochloride against Clinical Isolates of Bacteria, isolated from people in Russia and Spain
Aim to study antibacterial activity of benzydamine hydrochloride, against clinic isolated of bacteria, located in hospitals in Russia and compare this data to results of similar trail of Spanish isolates.MaterialsΒ andΒ methodΒ for this study were used clinical isolatesΒ of bacteria,Β which are counted as typical agentsΒ of infections in otorhinolaryngology and gynecology. Enterococcus spp., Escherichia coli, Klebsiella pneumoniae, Staphylococcus spp. and StreptococcusΒ spp.,Β isolated from patientsΒ in RussiansΒ hospitals;Β referenceΒ strainsΒ Escherichia coli, StaphylococcusΒ aureus and Streptococcus agalactiae, from ATCC collection; and also, Lactobacillus acidophilus strain, isolated from probiotic drug Β«LactobacterinΒ». Antibacterial activity of benzydamine hydrochloride was evaluated with serial dilution method in agar. For comparison of results we used data of Spanish study of benzydamine activity against clinical isolates and reference strains. The Spanish Study was completed in microbiological department of San-Pau hospital in Barcelona in 2001.Results.Β It was indicated that minimum inhibitory concentration (MIC) of benzydamine hydrochloride for clinical isolates of gram-negative and gram-positiveΒ bacteria, isolated from Russian and Spanish hospitals is about the same level: for E. coli it was 640 β 1280Β mg/l, for K. pneumoniaeΒ β 512β1280Β mg/l, for S. aureusΒ β 256β1280Β mg/l, for S. agalactiaeΒ β 320β1280Β mg/l, for S. pyogenes β 256β640 mg/l, for E. faecalis β 512 mg/l, for E. faecium β 256 mg/l, for S. mitis β 640 mg/l, for S. epidermidis 320 β 1280 mg/l, for S. pneumoniaeΒ βΒ 40 mg/l, for S. viridansΒ βΒ 40 mg/l. The same data was obtained by assessment of sensitivity to benzydamine hydrochloride reference-strains from ATCC collection: for E. coli MIC was 512 β 640 mg/l, for S. aureus β 512 β 640 mg/l, for S. agalactiae β 320 mg/l, for S. pneumoniae β 640 mg/l. Probiotic strain L. acidophilus was resistant to benzydamine hydrochloride activity with MIC = 20000 mg/l. Conclusion: It was indicated that antimicrobial activity of benzydamine hydrochloride against clinical strains, isolated from the patients of hospitals in Russia and Spain. Also, resistance of probiotic strain of lactobacteria was detected to this drug, which indicates the possibility of benzydamine hydrochloride application in clinical practice in otorhinolaryngologyΒ and gynecology without risk of negative influence on normal lactobacterial flora
PHENOTYPES AND GENOTYPES OF CLASSICAL AND HYPERVIRULENT KLEBSIELLA PNEUMONIAE CLINICAL STRAINS ISOLATED IN MOSCOW IN 2013β2018
Early Response of Antimicrobial Resistance and Virulence Genes Expression in Classical, Hypervirulent, and Hybrid hvKp-MDR Klebsiella pneumoniae on Antimicrobial Stress
Klebsiella pneumoniae is an increasingly important hospital pathogen. Classical K. pneumoniae (cKp) and hypervirulent K. pneumoniae (hvKp) are two distinct evolutionary genetic lines. The recently ongoing evolution of K. pneumoniae resulted in the generation of hybrid hvKP-MDR strains. K. pneumoniae distinct isolates (n = 70) belonged to 20 sequence types with the prevalence of ST395 (27.1%), ST23 (18.6%), ST147 (15.7%), and ST86 (7.1%), and 17 capsular types with the predominance of K2 (31.4%), K57 (18.6%), K64 (10.0%), K1 (5.7%) were isolated from patients of the Moscow neurosurgery ICU in 2014–2019. The rate of multi-drug resistant (MDR) and carbapenem-resistant phenotypes were 84.3% and 45.7%, respectively. Whole-genome sequencing of five selected strains belonging to cKp (ST395K47 and ST147K64), hvKp (ST86K2), and hvKp-MDR (ST23K1 and ST23K57) revealed blaSHV, blaTEM, blaCTX, blaOXA-48, and blaNDM beta-lactamase genes; acr, oqx, kpn, kde, and kex efflux genes; and K. pneumoniae virulence genes. Selective pressure of 100 mg/L ampicillin or 10 mg/L ceftriaxone induced changes of expression levels for named genes in the strains belonging to cKp, hvKp, and hybrid hvKp-MDR. Obtained results seem to be important for epidemiologists and clinicians for enhancing knowledge about hospital pathogens